Cargando…

Macrophage Migration Inhibitory Factor -173 G/C Polymorphism: A Global Meta-Analysis across the Disease Spectrum

Human macrophage migration inhibitory factor (MIF) is a cytokine that plays a role in several metabolic and inflammatory processes. Single nucleotide polymorphism (SNP) -173 G/C (rs755622) on MIF gene has been associated with numerous diseases, such as arthritis and cancer. However, most of the repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Illescas, Oscar, Gomez-Verjan, Juan C., García-Velázquez, Lizbeth, Govezensky, Tzipe, Rodriguez-Sosa, Miriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839154/
https://www.ncbi.nlm.nih.gov/pubmed/29545822
http://dx.doi.org/10.3389/fgene.2018.00055
_version_ 1783304365653622784
author Illescas, Oscar
Gomez-Verjan, Juan C.
García-Velázquez, Lizbeth
Govezensky, Tzipe
Rodriguez-Sosa, Miriam
author_facet Illescas, Oscar
Gomez-Verjan, Juan C.
García-Velázquez, Lizbeth
Govezensky, Tzipe
Rodriguez-Sosa, Miriam
author_sort Illescas, Oscar
collection PubMed
description Human macrophage migration inhibitory factor (MIF) is a cytokine that plays a role in several metabolic and inflammatory processes. Single nucleotide polymorphism (SNP) -173 G/C (rs755622) on MIF gene has been associated with numerous diseases, such as arthritis and cancer. However, most of the reports concerning the association of MIF with these and other pathologies are inconsistent and remain quite controversial. Therefore, we performed a meta-analysis from 96 case-control studies on -173 G/C MIF SNP and stratified the data according to the subjects geographic localization or the disease pathophysiology, in order to determine a more meaningful significance to this SNP. The polymorphism was strongly associated with an increased risk in autoimmune-inflammatory, infectious and age-related diseases on the dominant (OR: 0.74 [0.58–0.93], P < 0.01; OR: 0.81 [0.74–0.89], P < 0.0001; and OR: 0.81 [0.76–0.87], P < 0.0001, respectively) and the recessive models (OR: 0.74 [0.57–0.095], P < 0.01; OR: 0.66 [0.48–0.92], P < 0.0154; and OR: 0.70 [0.60–0.82], P < 0.0001, respectively). Also, significant association was found in the geographic localization setting for Asia, Europe and Latin America subdivisions in the dominant (OR: 0.76 [0.69–0.84], P < 0.0001; OR: 0.77 [0.72–0.83], P < 0.0001; OR: 0.61 [0.44–0.83], P-value: 0.0017, respectively) and overdominant models (OR: 0.85 [0.77–0.94], P < 0.0001; OR: 0.80 [0.75–0.86], P < 0.0001; OR: 0.73 [0.63–0.85], P-value: 0.0017, respectively). Afterwards, we implemented a network meta-analysis to compare the association of the polymorphism for two different subdivisions. We found a stronger association for autoimmune than for age-related or autoimmune-inflammatory diseases, and stronger association for infectious than for autoimmune-inflammatory diseases. We report for the first time a meta-analysis of rs755622 polymorphism with a variety of stratified diseases and populations. The study reveals a strong association of the polymorphism with autoimmune and infectious diseases. These results may help direct future research on MIF-173 G/C in diseases in which the relation is clearer and thus assist the search for more plausible applications.
format Online
Article
Text
id pubmed-5839154
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-58391542018-03-15 Macrophage Migration Inhibitory Factor -173 G/C Polymorphism: A Global Meta-Analysis across the Disease Spectrum Illescas, Oscar Gomez-Verjan, Juan C. García-Velázquez, Lizbeth Govezensky, Tzipe Rodriguez-Sosa, Miriam Front Genet Genetics Human macrophage migration inhibitory factor (MIF) is a cytokine that plays a role in several metabolic and inflammatory processes. Single nucleotide polymorphism (SNP) -173 G/C (rs755622) on MIF gene has been associated with numerous diseases, such as arthritis and cancer. However, most of the reports concerning the association of MIF with these and other pathologies are inconsistent and remain quite controversial. Therefore, we performed a meta-analysis from 96 case-control studies on -173 G/C MIF SNP and stratified the data according to the subjects geographic localization or the disease pathophysiology, in order to determine a more meaningful significance to this SNP. The polymorphism was strongly associated with an increased risk in autoimmune-inflammatory, infectious and age-related diseases on the dominant (OR: 0.74 [0.58–0.93], P < 0.01; OR: 0.81 [0.74–0.89], P < 0.0001; and OR: 0.81 [0.76–0.87], P < 0.0001, respectively) and the recessive models (OR: 0.74 [0.57–0.095], P < 0.01; OR: 0.66 [0.48–0.92], P < 0.0154; and OR: 0.70 [0.60–0.82], P < 0.0001, respectively). Also, significant association was found in the geographic localization setting for Asia, Europe and Latin America subdivisions in the dominant (OR: 0.76 [0.69–0.84], P < 0.0001; OR: 0.77 [0.72–0.83], P < 0.0001; OR: 0.61 [0.44–0.83], P-value: 0.0017, respectively) and overdominant models (OR: 0.85 [0.77–0.94], P < 0.0001; OR: 0.80 [0.75–0.86], P < 0.0001; OR: 0.73 [0.63–0.85], P-value: 0.0017, respectively). Afterwards, we implemented a network meta-analysis to compare the association of the polymorphism for two different subdivisions. We found a stronger association for autoimmune than for age-related or autoimmune-inflammatory diseases, and stronger association for infectious than for autoimmune-inflammatory diseases. We report for the first time a meta-analysis of rs755622 polymorphism with a variety of stratified diseases and populations. The study reveals a strong association of the polymorphism with autoimmune and infectious diseases. These results may help direct future research on MIF-173 G/C in diseases in which the relation is clearer and thus assist the search for more plausible applications. Frontiers Media S.A. 2018-03-01 /pmc/articles/PMC5839154/ /pubmed/29545822 http://dx.doi.org/10.3389/fgene.2018.00055 Text en Copyright © 2018 Illescas, Gomez-Verjan, García-Velázquez, Govezensky and Rodriguez-Sosa. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Illescas, Oscar
Gomez-Verjan, Juan C.
García-Velázquez, Lizbeth
Govezensky, Tzipe
Rodriguez-Sosa, Miriam
Macrophage Migration Inhibitory Factor -173 G/C Polymorphism: A Global Meta-Analysis across the Disease Spectrum
title Macrophage Migration Inhibitory Factor -173 G/C Polymorphism: A Global Meta-Analysis across the Disease Spectrum
title_full Macrophage Migration Inhibitory Factor -173 G/C Polymorphism: A Global Meta-Analysis across the Disease Spectrum
title_fullStr Macrophage Migration Inhibitory Factor -173 G/C Polymorphism: A Global Meta-Analysis across the Disease Spectrum
title_full_unstemmed Macrophage Migration Inhibitory Factor -173 G/C Polymorphism: A Global Meta-Analysis across the Disease Spectrum
title_short Macrophage Migration Inhibitory Factor -173 G/C Polymorphism: A Global Meta-Analysis across the Disease Spectrum
title_sort macrophage migration inhibitory factor -173 g/c polymorphism: a global meta-analysis across the disease spectrum
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839154/
https://www.ncbi.nlm.nih.gov/pubmed/29545822
http://dx.doi.org/10.3389/fgene.2018.00055
work_keys_str_mv AT illescasoscar macrophagemigrationinhibitoryfactor173gcpolymorphismaglobalmetaanalysisacrossthediseasespectrum
AT gomezverjanjuanc macrophagemigrationinhibitoryfactor173gcpolymorphismaglobalmetaanalysisacrossthediseasespectrum
AT garciavelazquezlizbeth macrophagemigrationinhibitoryfactor173gcpolymorphismaglobalmetaanalysisacrossthediseasespectrum
AT govezenskytzipe macrophagemigrationinhibitoryfactor173gcpolymorphismaglobalmetaanalysisacrossthediseasespectrum
AT rodriguezsosamiriam macrophagemigrationinhibitoryfactor173gcpolymorphismaglobalmetaanalysisacrossthediseasespectrum